BlackRock’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-740,524
Closed -$241K 5453
2023
Q2
$241K Sell
740,524
-98,178
-12% -$32K ﹤0.01% 4596
2023
Q1
$361K Buy
838,702
+2,582
+0.3% +$1.11K ﹤0.01% 4537
2022
Q4
$443K Buy
836,120
+1,368
+0.2% +$725 ﹤0.01% 4560
2022
Q3
$611K Sell
834,752
-8,931
-1% -$6.54K ﹤0.01% 4573
2022
Q2
$962K Buy
843,683
+5,224
+0.6% +$5.96K ﹤0.01% 4457
2022
Q1
$1.72M Buy
838,459
+2,811
+0.3% +$5.76K ﹤0.01% 4369
2021
Q4
$2.41M Sell
835,648
-5,505
-0.7% -$15.9K ﹤0.01% 4263
2021
Q3
$3.57M Buy
841,153
+66,889
+9% +$284K ﹤0.01% 4010
2021
Q2
$4.1M Buy
774,264
+179,243
+30% +$948K ﹤0.01% 3899
2021
Q1
$2.77M Buy
595,021
+189,103
+47% +$879K ﹤0.01% 4118
2020
Q4
$1.34M Buy
405,918
+18,793
+5% +$62K ﹤0.01% 4070
2020
Q3
$1.28M Sell
387,125
-51,518
-12% -$170K ﹤0.01% 3940
2020
Q2
$1.48M Sell
438,643
-1,069,965
-71% -$3.61M ﹤0.01% 3839
2020
Q1
$5.78M Sell
1,508,608
-4,997
-0.3% -$19.1K ﹤0.01% 3234
2019
Q4
$9.14M Buy
1,513,605
+68,824
+5% +$416K ﹤0.01% 3248
2019
Q3
$10.9M Buy
1,444,781
+132,786
+10% +$1M ﹤0.01% 3130
2019
Q2
$17.8M Buy
1,311,995
+1,014,749
+341% +$13.8M ﹤0.01% 2882
2019
Q1
$1.61M Sell
297,246
-3,703
-1% -$20.1K ﹤0.01% 3736
2018
Q4
$893K Buy
300,949
+2,594
+0.9% +$7.7K ﹤0.01% 3883
2018
Q3
$2.44M Buy
298,355
+59,998
+25% +$490K ﹤0.01% 3656
2018
Q2
$2.32M Sell
238,357
-476,828
-67% -$4.65M ﹤0.01% 3640
2018
Q1
$6.22M Buy
715,185
+36,488
+5% +$317K ﹤0.01% 3313
2017
Q4
$8.5M Buy
678,697
+7,091
+1% +$88.8K ﹤0.01% 3193
2017
Q3
$5.61M Buy
671,606
+11,908
+2% +$99.5K ﹤0.01% 3383
2017
Q2
$11.2M Buy
659,698
+461,215
+232% +$7.83M ﹤0.01% 3072
2017
Q1
$3.99M Buy
+198,483
New +$3.99M ﹤0.01% 3419